Figure 3From: A multicenter phase II study of everolimus in patients with progressive unresectable adenoid cystic carcinoma Percent changes in maximum standardized uptake values (SUVmax) after 2 cycles of everolimus treatment (FDG- PET evaluable patients, N = 18). Back to article page